Local view for "http://purl.org/linkedpolitics/eu/plenary/2009-05-05-Speech-2-187"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20090505.19.2-187"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:spokenAs | |
| lpv:translated text |
"It was time for the partners concerned to consider the welfare of animals used for research purposes and the ban on trapping wild monkeys for use by breeding farms, which results in violence; stress during capture, then confinement; the separation of family groups; the splitting up of social groups; an impact on the environment; the disturbance of the natural balance of the population; and the withdrawal of females.
We will therefore support the aim of making maximum use of animals bred for this purpose whose genetic and medical history are known, and who therefore offer greater consistency and comparability of data.
If, on the other hand, the animal welfare standards used for research purposes resulted in the exporting of research, the impact would then be more obvious in those countries which already operate under strict regulatory controls, such as Switzerland and the United Kingdom. The fact is, in those countries the pharmaceutical industry has continued to prosper despite 20 years of strict regulation. Regulation has not, therefore, curbed the success of this industry. The controls have even improved the standards of scientific practices. This therefore confirms the fear of seeing research exported in the wake of these regulations."@en1
|
Named graphs describing this resource:
The resource appears as object in 2 triples